Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Crouch

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|February 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategiesAleksandar Savic, Adele Taylor, Pierre Fenaux, et al.
British Journal of Haematology|May 21, 2024
Inflammatory profile of lower risk myelodysplastic syndromesJoanne Topping, Adele Taylor, Fatima Nadat, et al.
British Journal of Haematology|November 6, 2022
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registryKrzysztof Mądry, Karol Lis, Pierre Fenaux, et al.
The Lancet. Haematology|February 5, 2025
Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort studyHege Kristin Gravdahl Garelius, Timothy Bagguley, Adele Taylor, et al.
Leukemia|December 18, 2019
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hitFrancesco Cucco, Sharon Barrans, Chulin Sha, et al.
The Journal of Pathology. Clinical Research|June 28, 2016
The prognosis of <i>MYC</i> translocation positive diffuse large B-cell lymphoma depends on the second hitAlexandra Clipson, Sharon Barrans, Naiyan Zeng, et al.
Blood Advances|August 22, 2018
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromesRaphael Itzykson, Simon Crouch, Erica Travaglino, et al.
Blood Advances|August 13, 2021
A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDSHoward S Oster, Simon Crouch, Alexandra Smith, et al.
Haematologica|June 8, 2019
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromesLouise de Swart, Simon Crouch, Marlijn Hoeks, et al.
Haematologica|October 15, 2020
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspectiveTheo De Witte, Luca Malcovati, Pierre Fenaux, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|February 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategiesAleksandar Savic, Adele Taylor, Pierre Fenaux, et al.
British Journal of Haematology|May 21, 2024
Inflammatory profile of lower risk myelodysplastic syndromesJoanne Topping, Adele Taylor, Fatima Nadat, et al.
British Journal of Haematology|November 6, 2022
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registryKrzysztof Mądry, Karol Lis, Pierre Fenaux, et al.
The Lancet. Haematology|February 5, 2025
Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort studyHege Kristin Gravdahl Garelius, Timothy Bagguley, Adele Taylor, et al.
Leukemia|December 18, 2019
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hitFrancesco Cucco, Sharon Barrans, Chulin Sha, et al.
The Journal of Pathology. Clinical Research|June 28, 2016
The prognosis of <i>MYC</i> translocation positive diffuse large B-cell lymphoma depends on the second hitAlexandra Clipson, Sharon Barrans, Naiyan Zeng, et al.
Blood Advances|August 22, 2018
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromesRaphael Itzykson, Simon Crouch, Erica Travaglino, et al.
Blood Advances|August 13, 2021
A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDSHoward S Oster, Simon Crouch, Alexandra Smith, et al.
Haematologica|June 8, 2019
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromesLouise de Swart, Simon Crouch, Marlijn Hoeks, et al.
Haematologica|October 15, 2020
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspectiveTheo De Witte, Luca Malcovati, Pierre Fenaux, et al.
Pageof 7